- A Case of Multiple Hepatocellular Carcinoma which was Performed Liver Transplantation after Down-staging by Transcatheter Arterial Chemoembolization
-
Hee-Jung Wang, Bong-Wan Kim, Sung-Won Cho, Je-Hwan Won
-
Journal of the Korean Liver Cancer Study Group. 2011;11(1):50-55. Published online February 28, 2011
-
-
-
Abstract
PDF
- A case of multiple hepatocellular carcinoma (HCC) which was performed a living donor liver transplantation (LDLT) after
down-staging by transcatheter arterial chemoembolization (TACE) is reviewed. Generally, the recommended therapeutic
strategy for this kind of HCC is TACE. However, the response of multiple HCC of this 48 year-old male patient was relatively
good after 4 times of TACE, and we performed LDLT on the concept of clinical trial under the informed consent of patient and
his families. Although there were two times recurrences in the liver and lung, he has overcome them and is still alive 66 months
after LDLT. We suggest that liver transplantation could be an alternative strategy in the multiple HCC cases who show good
responses after TACE.
- A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombi which was Performed Hepatectomy after Down-staging by Proton Therapy
-
Hee-Jung Wang, Bong-Wan Kim, Wei-Kwang Xu
-
Journal of the Korean Liver Cancer Study Group. 2011;11(1):56-59. Published online February 28, 2011
-
-
-
Abstract
PDF
- A case of hepatocellular carcinoma (HCC) with portal vein tumor thrombi (PVTT) which was performed hepatectomy after
down-staging by proton therapy is reviewed. Generally, the recommended therapeutic strategy for this kind of HCC is radiation
therapy, systemic or infusion anticancer chemotherapy. However, the response of HCC and its PVTT of this 56 year-old male
patient was relatively good after 22 times of proton therapy, and we performed right hemihepatectomy on the concept of clinical
trial under the informed consent of patient and his families. He is still alive without recurrence 15 months after hepatectomy. We
suggest that hemihepatectomy with removal of PVTT could be an alternative strategy in the PVTT accompanied HCC cases who
show good responses after the above generally recommended therapies.
|